Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Huaian
Clinical trial register · China

Clinical Trials in Huaian, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19347 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:17 UTC
19347
Studies in scope
all four open statuses
11884
Recruiting now
open to new participants
2035
Lead sponsors
across recruiting studies
Top sites
Beijing 5618 Shanghai 3907 Guangzhou 3368 Hangzhou 1835 Wuhan 1343

Trials with a site in Huaian

11 of 19347 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4
50
Fuyang, Zhengzhou, Zhoukou, Huaian, Yancheng, Meihekou, Shanghai
2026-09-23
Recruiting
AstraZeneca
Phase 3
4,500
Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian
2026-06-29
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,000
Nanjing, Ankang, Datong, Ganzhou, Hangzhou, Huaian, Nanning, Shanghai
2026-05-22
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc.
Phase 2
218
Yangzhou, Tianjin, Hangzhou, Huaian, Shanghai
2025-08-19
Active, closed
Amgen
Phase 4
102
Beijing, Guangzhou, Shenzhen, Luoyang, Wuhan, Changzhou, Huaian, Nantong
2025-05-24
Recruiting
Fudan University
Phase 2
208
Fuzhou, Xiamen, Lanzhou, Zhengzhou, Huaian, Jinan, Taian, Shanghai
2025-03-01
Active, closed
The Second People's Hospital of Huai'an
Phase 1/2
144
Huaian
2025-03-01
Not yet open
Nanjing Broad Biopharmaceutical Ltd.
Observational
300
Huaian, Suzhou, Xuzhou, Yangzhou
2025-03-01
Recruiting
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
NCT03547232Acute Pancreatitis, Complication, Mortality Rate, Organ Failure, Multiple
Peking Union Medical College Hospital
Phase 4
1,504
Beijing, Guiyang, Baoding, Harbin, Dengzhou, Nanyang, Huaian, Nantong
2024-12-01
Active, closed
Amgen
Phase 4
102
Beijing, Chongqing, Guangzhou, Harbin, Huaian, Nanjing, Suzhou, Xuzhou
2024-08-06
Active, closed
AbbVie
Phase 3
1,242
Hefei, Beijing, Guangzhou, Shijiazhuang, Wuhan, Changsha, Huaian, Nanjing
2018-08-28
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-china/city/huaian

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,347 studies in total at the last sync on 18 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Huaian.

How many clinical trials are recruiting in Huaian?

6 of the 11 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Huaian), 11 studies
PhaseStudiesRecruitingShare
Phase 44236.4%
Observational2118.2%
Phase 22218.2%
Phase 32118.2%
Phase 1/2109.1%

Most active sponsors

Lead sponsors with the most studies (Huaian)
Lead sponsorStudiesRecruiting
Amgen20
AbbVie10
Astellas Pharma Global Development, Inc.11
AstraZeneca11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.11
Fudan University11
Nanjing Broad Biopharmaceutical Ltd.10
Peking Union Medical College Hospital11
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School11
The Second People's Hospital of Huai'an10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.